Innovasis enters partnership to expand into biologics market: 5 insights


Spinal device company Innovasis partnered with Stability Biologics to enter the biologics market.

Here are five things to know:

1. Under the private-label agreement, Innovasis will receive Stability Biologics' private labeled bone allograft tissue products, including its flagship product, Physio.

2. Physio a physiologic bone tissue allograft made of donated human tissue, with no added extrinsic carrier.

3. Innovasis Director of Business Development and Clinical Affairs David Oka said, "We anticipate Physio's differentiated osteogenic microstructure will provide a potent ecosystem when used with our PEEK-Optima HA Enhanced interbody platform."

4. Innovasis expects to commercialize its private-labeled product lines by December.

5. Stability Biologics provides human allograft tissue products for spine, orthopedic and wound care applications.


Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Webinars

Featured Whitepapers